Drug therapy to achieve the recommended target blood pressure remains the cornerstone of
the management of hypertension. Today, there are strong evidences from randomized …

Introduction: Current guidelines for pharmacotherapy briefly describe a role for combination
antihypertensive therapy. However, guidance on whether combination therapy should be …

Hypertension is a major preventable risk factor for atherosclerosis and ischemic heart
disease. Although modern and effective antihypertensive drugs are available, most patients …

Current blood pressure treatment guidelines call for a single drug to be tried first in people
with Stage 1 hypertension, ie those with a systolic reading over 140 mmHg and a diastolic …

Importance of the field: Despite extensive clinical research, still there is some uncertainty
regarding management of hypertension, in particular initial and goal blood pressure levels …

Despite the widespread availability of several effective classes of drugs, systemic arterial
hypertension remains poorly controlled in the majority of patients worldwide. In this article …

Pharmacological treatment of hypertension represents a cost‐effective way for preventing
cardiovascular and renal complications. To benefit maximally from antihypertensive …

Arterial Hypertension (AH) has a high prevalence in the population worldwide and
represents the most important risk factor for cardiovascular (CV) mortality and morbidity. The …

Arterial hypertension is a widely prevalent risk factor for cardiovascular diseases with well
documented harmful effects on the heart and the vascular system. Despite a broad …

Introduction: Hypertension is one of the primary modifiable risk factor for cardiac and renal
diseases with the prevalence around 30–45% of the general population, with a steep …